Bioinformatics Advance Access originally published online on December 5, 2006
Bioinformatics 2007 23(3):281-288; doi:10.1093/bioinformatics/btl620
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genomic sweeping for hypermethylated genes
Institute for Genome Sciences Policy, Duke University
*To whom correspondence should be addressed.
| Abstract |
|---|
Motivation: Genes silenced by the aberrent methylation of nearby CpG islands can contribute to the onset or progression of cancer and represent potential biomarkers for diagnosis and prognosis. Relatively few have thus far been validated as hypermethylated in cancer among over 14 000 candidates with promoter region CpG islands. A descriptive set of genes known to be unmethylated in cancer does not exist. This lack of a negative set and a large number of candidates necessitated the development of a new approach to identify novel genes hypermethylated in cancer.
Results: We developed a general method, cluster_boost, that in an imbalanced data setting predicts new minority class members given limited known samples and a large set of unlabeled samples. Synthetic datasets modeled after the hypermethylated genes data show that cluster_boost can successfully identify minority samples within unlabeled data. Using genome sequence features, cluster_boost predicted candidate hypermethylated genes among 14 000 genes of unknown status. In primary ovarian cancers, we determined the methylation status for 15 genes with different levels of support for being hypermethlyated. Results indicate cluster_boost can accurately identify novel genes hypermethylated in cancer.
Availability: Software and datasets are freely available at http://labs.genome.duke.edu/FureyLab/cluster_boost.php
Contact: tsfurey{at}duke.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
Associate Editor: Christos Ouzounis
Received on July 24, 2006; revised on November 15, 2006; accepted on December 1, 2006
This article has been cited by other articles:
![]() |
M. T. McCabe, J. C. Brandes, and P. M. Vertino Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications Clin. Cancer Res., June 15, 2009; 15(12): 3927 - 3937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, H.-i. H. Paik, C. Balch, Y. Kim, L. Li, T. H-M. Huang, K. P. Nephew, and S. Kim Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells Bioinformatics, August 15, 2008; 24(16): 1745 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bock and T. Lengauer Computational epigenetics Bioinformatics, January 1, 2008; 24(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||

